RPRX — ROYALTY PHARMA PLC FCLASS A

Ownership history in PACK Private Wealth, LLC  ·  16 quarters on record

This page tracks every 13F SEC filing in which PACK Private Wealth, LLC reported a position in ROYALTY PHARMA PLC FCLASS A (RPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.67% (2022 Q2)
Avg. % of fund
0.4%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 17,414 — 0% 0.31% $673K $38.44
2025 Q3 UNCHANGED 17,414 — 0% 0.29% $614K $34.90
2025 Q2 UNCHANGED 17,414 — 0% 0.33% $627K $35.43
2025 Q1 UNCHANGED 17,414 — 0% 0.32% $542K $30.41
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RPRX price (monthly, adj. close)

Other funds also holding RPRX

As of 2025 Q4 — sorted by position size

Dorsey Asset Management, LLC 3Y 7Y 7.59% Regal Partners Ltd 3Y 7Y 5.88% Caledonia (Private) Investments Pty Ltd 3Y 7Y 5.46% NEW SOUTH CAPITAL MANAGEMENT INC 3Y 7Y 5.21% Patient Capital Management, LLC 3Y 4.97% Lion Point Capital, LP 3Y 7Y 4.28% TORRAY INVESTMENT PARTNERS LLC 3Y 7Y 4.12% Goodman Advisory Group, LLC 3Y 2.67% CM Management, LLC 3Y 2.44% Inlet Private Wealth, LLC 3Y 7Y 2.02%
← Back to PACK Private Wealth, LLC Holdings